Document Detail


Clinicopathological roles of aberrantly expressed recoverin in malignant tumor cells.
MedLine Citation:
PMID:  19887879     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Cancer-associated retinopathy (CAR) is an ocular manifestation of a paraneoplastic syndrome whereby immunological reactions toward recoverin, a retina-specific calcium binding protein, and other retinal antigens aberrantly expressed in tumor cells are elicited. As a consequence, photoreceptor cell degeneration is induced. To elucidate the pathological role of the aberrantly expressed recoverin, we studied the recoverin expression levels in various malignant tumors and the effects of the expressed recoverin on the sensitivity to anti-cancer drugs. METHODS: Recoverin expression levels were determined by immunohistochemistry with anti-human recoverin monoclonal antibody on multiple tissue arrays obtained from several lung, stomach, colon and other cancers. In the presence of several anti-cancer drugs, including anti-tumor antibiotics, plant alkaloids and anti-metabolites, cytotoxicity assay was performed using recoverin-positive or recoverin-negative A549 cells originating from human lung adenocarcinoma. RESULTS: Immunofluorescence labeling revealed that recoverin immunoreactivities were detected at approximately 10-40% of malignant tumor tissues. Cytotoxic effects by anti-cancer drugs were higher in recoverin-positive A549 cells as compared to recoverin-negative cells. CONCLUSION: The present data may correlate with the previous observation that recoverin-expressing cancer cells induced tumor immunity and a favorable prognosis for primary cancer in CAR patients.
Authors:
Sachiyo Matsuo; Hiroshi Ohguro; Ikuyo Ohguro; Mitsuru Nakazawa
Related Documents :
25388399 - Isolation and culture of primary glioblastoma cells from human tumor specimens.
1394139 - Simian virus 40 large t antigen directed by transcriptional elements of the human surfa...
2758559 - Effects of two pyridinalalkyliminerhodium(i) complexes in mice bearing mca mammary carc...
24436899 - Fully endoscopic resection of pineal region tumors.
23433329 - Rehabilitation and treatment of spinal cord tumors.
25275109 - Fluorodeoxyglucose-based positron emission tomography imaging to monitor drug responses...
25287069 - Targeting gpr30 with g-1: a new therapeutic target for castration-resistant prostate ca...
3031479 - Identification of a new common provirus integration site in gross passage a murine leuk...
10656729 - Overexpression of cyclin a and cyclin b1 proteins in astrocytomas.
Publication Detail:
Type:  Journal Article     Date:  2009-10-30
Journal Detail:
Title:  Ophthalmic research     Volume:  43     ISSN:  1423-0259     ISO Abbreviation:  Ophthalmic Res.     Publication Date:  2010  
Date Detail:
Created Date:  2010-02-22     Completed Date:  2010-04-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0267442     Medline TA:  Ophthalmic Res     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  139-44     Citation Subset:  IM    
Copyright Information:
Copyright 2009 S. Karger AG, Basel.
Affiliation:
Department of Ophthalmology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology
Cell Line, Tumor
Cell Proliferation
Fluorescent Antibody Technique, Indirect
Gene Expression Regulation, Neoplastic / physiology*
Humans
Neoplasms / drug therapy,  genetics*,  pathology*
Recoverin / genetics*,  metabolism
Transfection
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/RCVRN protein, human; 135844-11-0/Recoverin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preliminary results of subconjunctival bevacizumab in primary pterygium excision.
Next Document:  In vitro Prevention of Vaccinia and Herpesvirus Infection Spread in Explanted Human Corneas by N-Chl...